PWE-347 Adherent, invasive mucosa-associated e. coli isolates from colorectal cancer patients activate WNT signalling
Authors: B Meehan, B Campbell, J Rhodes
Journal: Gut (2015)

<h3>Introduction</h3> Increased numbers of adherent, invasive E.coli (AIEC) have been reported on and within intestinal epithelial cells of patients with colorectal cancer (CRC).<sup>1</sup>Cancer-inducing activity of AIEC have recently been described by our group and others, including potential for genotoxicity and promotion of angiogenesis.<sup>2,3,4</sup>We hypothesise that CRC-associated AIEC may also trigger key cancer signalling pathways that support development and progression of early carcinogenesis, including (Wingless) Wnt/b-catenin cell signalling pathway.<sup>5</sup> <h3>Method</h3> Two human CRC cell-lines SW-480 and DLD1 were infected with CRC mucosa-associated AIEC isolates HM44 and HM358<sup>1</sup>for 4h at multiplicity of infection of 10. RNA was isolated, and synthesised cDNA subjected to RT<sup>2</sup>PCR Wnt Target Array (84 Wnt-relevant genes). Gene expression changes were confirmed by Roche Lightcycler qPCR and protein expression by immunoblot (0.5h to 4h infections). <h3>Results</h3> In response to 4h infection with CRC-associated AIEC isolates HM44 and HM358, 11 Wnt target-genes were significantly up-regulated and 7 significantly down-regulated, many regulating cell cycle, cell proliferation, migration and angiogenesis. Key genes up-regulated in SW480 cells included cyclooxygenase-2 (<i>PTGS-2/COX2</i>), increased 8.1 ± 0.9 and 9.2 ± 1.0 fold (both P = 0.0002), Fos-related antigen 1 (<i>FOSL1</i>) increased 6.1 ± 0.6 and 7.9 ± 1.9 fold (P &lt; 0.01), and vascular endothelial growth factor-A (<i>VEGFA</i>) upregulated 4.6 ± 0.3 and 4.2 ± 0.2 fold respectively (P &lt; 0.0001). Down-regulated genes (&gt;2 fold change) included a known CRC tumour suppressor, Wnt-1 inducible signalling pathway 2 (<i>WISP2</i>); P &lt; 0.05. Similar gene changes were seen using DLD-1 cells, and confirmed by qPCR. AIEC also significantly increased cellular protein levels; e.g. COX2, up 5.7 ± 0.7 and 2.8 ± 0.04 fold respectively (both P &lt; 0.01; N=3, n = 3). In addition, b-catenin increases were 2–3 fold at 2h and 4h post-infection (P &lt; 0.05). <h3>Conclusion</h3> Early indications suggest a key contribution of cancer-promoting activity of CRC-mucosa-associated E.coli events may be through ability to activate the Wnt signalling pathway. Confirmation of the importance of these findings is being investigated <i>in vivo</i>using a mono-association mouse model,<sup>2</sup>along with a CRC E.coli fosmid-library screening approach<sup>3</sup>to identify specific bacterial factors triggering these early cancer-promoting signals. <h3>Disclosure of interest</h3> B. Meehan: None Declared, B. Campbell Conflict with: Received honoraria from Amgen and Falk., J. Rhodes Conflict with: Is/has been a member of advisory boards for Atlantic, Procter and Gamble and Falk, has received honoraria from Abbott, Falk, Ferring, Glaxo Smith Kline, Procter and Gamble and Schering Plough. <h3>References</h3> Martin, <i>et al</i>. Gastroenterology 2004;127:80–93 Arthur JC, <i>et al</i>. Science 2012;338:120–23 Prorok-Hamon M, <i>et al</i>. Gut 2014;63:761–70 Buc, <i>et al</i>. PLoS One 2013;8(2):e56964 Schneikert J, Behrens J. <i>Gut</i>2007;56:417–25